Open AccessSome aspects of maintaining patients with primary immunodeficiencies with antibodies synthesis disfunction. Data on 10% intravenous immunoglobulin G Gamunex treatment
Author(s) -
Elena A. Latysheva,
N. H Setdikova,
Т В Латышева
Publication year - 2012
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja722
Subject(s) - antibody , medicine , primary immunodeficiency , immunology , intravenous use , intensive care medicine , immune system , anesthesia
On time diagnostics and correct treatment of patients with PID with humoral deficiency provide a good prognosis. Despite of long experience of intravenous immunoglobulins (IVIG) usage for the treatment of these patients no strict recommendations concerning regimes of treatment exist. This article presents clinical experience about the treatment with 10% IVIG Gamunex in PID patients with immunoglobulin deficiency.